Effect of TIVA With Magnesium Sulfate on IONM in Patients Undergoing Spine Surgery

January 19, 2021 updated by: Essam M. Manaa (MD), King Khalid University Hospital

Effect of Total Intravenous Anesthesia (TIVA) With Magnesium Sulfate on Intra-Operative Neuromonitoring (IONM) in Patients Undergoing Spine Surgery

Anesthesia for neurosurgery requires balancing deep and effective anesthesia as well as postoperative analgesia versus the risks of delayed recovery and postoperative respiratory depression. This randomized placebo-controlled, double-blind study was designed to evaluate the effect of magnesium sulfate on the total anesthetic and analgesic consumption using the clinical parameters in addition to the effect on IONM reading.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Objectives:

  1. Decrease anesthetic consumption
  2. Decrease use of muscle relaxants
  3. Decrease analgesic consumption
  4. Excellent recovery

Patients & Methods:

  • 2 groups (total 50) Randomized Controlled Double Blind (RCDB) Study
  • Propofol + remifentanil + saline (Control = C group)
  • Propofol + remifentanil + Mgso4 (Magnesium = M group)
  • Adult Spine decompression and fixation After getting the Institutional Review Board (IRB) approval, This randomized controlled double blind study includes 2 groups of patients (each group 25) will be enrolled in the study. All patients undergo spine decompression and fixation surgery

Induction:

All patients in the study will receive iv fentanyl 2 mic/kg + propofol 2mg/kg and endotracheal intubation will be facilitated with rocuronium 0.60 mg/ kg. Then anesthesia will be maintained using total intravenous anesthesia with propofol (6-9 mg/kg/hr) + remifentanil (0.03-0.05 mic / kg/ min) Group 1 (C group) : Receive 10 mg/kg /hr 0.9% Normal Saline Group 2 (M group) : Receive 10 mg/kg/hr Magnesium Sulfate

Monitoring:

  1. IONM
  2. train-of-four (TOF)
  3. bispectral index (BIS)

Measurements:

  1. IO Anesthetic Consumption
  2. IO Hemodynamics
  3. somatosensory evoked potential (SSEP), motor evoked potential (MEP), TOF, BIS Readings
  4. PO visual analogue scale (VAS) (24hours)
  5. PO Morphine Consumption (24hours)

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Riyadh, Saudi Arabia
        • Anesthesia Department, Faculty of Medicine, King Khalid University Hospital, King Saud University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult ASA 1OR 2

Description

Inclusion Criteria:

  • Adult Patients Undergoing Spine Surgery

Exclusion Criteria:

  1. Renal Impairment
  2. Liver Cell failure
  3. Heart Block

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
magnesium sulfate effect on IONM reading in spine surgery
one group receives magnesium other do not
spine decompression and fixation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IONM Reading
Time Frame: 1- baseline 2-during surgery 3-immediately after surgery
Reading the effect on the intraoperative neuromonitoring either motor or sensory evoked potential
1- baseline 2-during surgery 3-immediately after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Pressure
Time Frame: 1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hours
Systolic, Diastolic and Mean (mmHg)
1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hours
Heart Rate
Time Frame: 1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hours
beats/min
1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hours
Morphine Consumption
Time Frame: Over 24 hours postoperative
Total morphine consumed over 24 hours in mg
Over 24 hours postoperative
Pain Score
Time Frame: Over 24 hours postoperative
11 Visual Analogue Scale (VAS) with 10 is the worst and 0 is the least
Over 24 hours postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ESSAM M MANAA, MD, Assistant Professor and Consultant, Anesthesia Department, Faculty of Medicine, KKUH, KSU, Riyadh, Saudi Arabia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2021

Primary Completion (Anticipated)

September 1, 2021

Study Completion (Anticipated)

October 1, 2021

Study Registration Dates

First Submitted

January 11, 2021

First Submitted That Met QC Criteria

January 15, 2021

First Posted (Actual)

January 20, 2021

Study Record Updates

Last Update Posted (Actual)

January 22, 2021

Last Update Submitted That Met QC Criteria

January 19, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • E-20-4965

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spine Surgery

Clinical Trials on Spine Surgery

3
Subscribe